Dr. A. M. Hutber, Co-Director, EpiVet Ltd, UK
Dr. Afzal A. Siddiqui, Professor, Microbiology & Immunology, School of Medicine, Texas Tech University Health Sciences Center, Germany
Dr. Ahmed Darwish, Team Leader, WHO PEI / EPI, Pakistan
Dr. Aini Ideris, Dean, School of Graduate Studies, University Putra, Malaysia
Dr. Alan Shaw, CEO of VaxInnate, USA
Dr. Albert Osterhaus, Head of the Department of Virology, Erasmus University, the Netherlands
Dr. Alexander Knuth, Director & Chairman, Department of Oncology, University Hospital Zurich, Switzerland
Dr. Alexander Panin, Director, All Russian States Center for Quality and Standardization of Veterinary Drug and Feedstuff Ministry of Agriculture of the Russian Federation, Russia
Dr. Anas Younes, Professor & Director, Department of Lymphoma/Myeloma, Anderson Cancer Center, USA
Dr. Andrew J. Moulden, President & CEO, CNAPS Medical Devices Inc., Canada
Dr. Andrzej Szkaradkiewicz, Professor & Chairman, University of Medical Sciences in Poznan, Poland
Dr. Anil K. Nair, Director, Neurology Quincy Medical Center, Alzheimers Disease Center, USA
Dr Anne Hosmalin, Head, Paris-Descartes University, France
Dr. Anne-Francoise Petavy, Laboratory of Parasitology and Medical Mycology, Faculty of Pharmacy, Claude- Bernard University, Lyon, France
Dr. Anselmo de Jesus Otero Gonzalez, Head of Analytical Unit, Centre for Protein Studies, Cuba
Dr. Anthony P. Carr, Associate Professor, Small Animal Clinical Sciences, Western College of Veterinary Medicine, Canada
Dr. Atmaram H. Bandivdekar, Director, National Institute for Research in Reproductive Health, India
Dr. B. G. Rhee, Executive Vice President, Green Cross Corporate, Korea
Dr. Bali Pulendran, Professor, Emory Vaccine Center, Emory University School of Medicine, USA
Dr. Bent Jakobsen, Senior Vice President Research, MediGene Limited, UK
Dr. Bernard Ivanoff, Senior Scientific Adviser, Foundation Mérieux, Switzerland
Dr. Bjorn Gustafsson, Associate Professor, Senior Scientific Adviser Crucell / SBL Vaccines, Sweden
Dr. Brendon Coventry, Professor, University of Adelaide, Australia
Dr. Brigitte Gicquel, Director of the Microbial Pathogenesis Department, Institute Pasteur, France
Dr. Brin Wong, Director, Inflammation, Autoimmunity & Transplantation Research Roche Palo Alto, LLC, USA
Dr. Cecil Czerkinsky, Deputy Director, International Vaccine Institute, Korea
Dr. Chang H. Kim, Associate Professor of Immunology, Purdue University, USA
Dr. Changping Zou, Manager, Beijing Minhai Biotechnology Co., Ltd, China
Dr. Ciro A. de Quadros, Executive Vice-President, Albert B. Sabin Vaccine Institute (SVI), USA
Dr. Claudio Soto, Professor, Department of Pathology, New York University Medical Center, USA
Dr. Cosette M. Wheeler, Professor, Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center School of Medicine, USA
Dr. Cyril Gerard Gay, National Program Leader, Animal Production and Protection, USDA, USA
Dr. Danilo Casimiro, Director, Department of Viral Vaccine Research, Merck Research Laboratories, Merck & Co, USA
Dr. David B. Weiner, Chair, Gene Therapy and Vaccine Program, CAMB University of Pennsylvania, USA
Dr. Dennis J. Kopecko, Chief, U.S. FDA – Center for Biologics Evaluation and Research, USA
Dr. Derek Hart, Director, Mater Medical Research Institute, Australia
Dr. Dieter Klein, Professor, Institute for Virology, Vetmeduni Vienna, Austria
Dr. Do Si Hien, Professor, National Institute of Hygiene and Epidemiology, Vietnam
Dr. Don Francis, Executive Director, Global Solutions for Infectious Diseases, USA
Dr. Donald P. Francis, Executive Director, Global Solutions for Infectious Diseases, USA
Dr. Eftyhia Vardas, Director, HIV/AIDS Vaccine Division, University of the Witwatersrand, South Africa
Dr. Emanuele Montomoli, Professor, Lab Molecular Epidemiology, University of Siena, Italy
Dr. Erich Tauber, Vice President, Clinical Development; Medical Officer, Clinical Development, Intercell AG, Austria
Dr. Francesca Granucci, Professor, Department of Biotechnology and Biosciences, University of Milano–Bicocca, Italy
Dr. Ernesto Marques, Central Lab Chief, the Centro Pesquisa Aggeu Magalhaes / Fundacao Oswaldo Cruz, Brazil
Dr. Firdausi Qadri, Senior Scientist & Head of the Immunology Laboratory, ICDDR, Bangladesh
Dr. Francesco Berti, Head, Physicochemical Immunochemical Unit, Novartis Vaccines and Diagnostics, Italy
Dr. Francesco Scarlata, Professor, University of Palermo, Italy
Dr. Francis Andre, Former Vice President, GlaxoSmithKline Biologicals, Belgium
Dr. Francisco Diaz-Mitoma, Professor & Chief, Division of Virology, University of Ottawa, Canada
Dr. Francoise Baylis, Professor of Medicine, Dalhousie University, Canada
Dr. Frank Tung, Founder & CEO, GeneCure Biotechnologies, USA
Dr. Friedrich Horak, Professor, University Hospital of Vienna, Austria
Dr. Garry T. Cole, Professor of Biology & Margaret Batts Tobin Endowed Chair, University of Texas at San Antonio, USA
Dr. Gary Grohmann, Associate Professor, FASM, Therapeutic Goods Administration Laboratories, Australia
Dr. George K. Lewis, Professor & Co-Director, Division of Basic Science and Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, USA
Dr. Giampietro Corradin, Associate Professor, Biochemistry Institute, University of Lausanne, Switzerland
Dr. Girish N. Vyas, Professor, Department of Laboratory Medicine, UCSF School of Medicine, USA
Dr. Guy Cardineau, Research Professor, University of Alabama at Birmingham, USA
Dr. Haifa Zheng, Chief Scientist & Vice General Manager, Beijing Minhai Biotechnology Co., Ltd, China
Dr. Hans J. Netter, Senior Lecturer & Unit Head, Department of Microbiology Clayton Campus, Australia
Dr. Hans Lutz, Professor, Clinical Laboratory, University of Zurich, Switzerland
Dr. Hans Wolf, Director, Institute for Medical Microbiology and Hygiene, University of Regensburg, Germany
Dr. Hilary Koprowski, President, Biotechnology Foundation Laboratories, Inc., USA
Dr. Hogarth Philip, Senior Scientist, Vaccine Immunology TB Research Group Veterinary Laboratories Agency, UK
Dr. Januario E. Castro, Associate Clinical Professor, University of California San-Diego, USA
Dr. Jonathan J. Lewis, President & CEO, ZIOPHARM Oncology Inc., USA
Dr. J. J. Roord, Professor, VU University, The Netherlands
Dr. Joseph Monsonego, Medical Director, Institute of the Cervix, France
Dr. J. M. Okwo-Bele, Director, Immunization, Vaccines and Biologicals Department, WHO, Switzerland
Dr. Jabbar Ahmed, Professor, Division of Veterinary Infection Biology and Immunology, Germany
Dr. Jan Holmgren, Professor, Gothenburg University, Sweden
Dr. Janet Chantler, Professor, Pathology and Laboratory Medicine, University of British Columbia, Canada
Dr. Jann Hau, Professor, Department of Experimental Medicine, University of Copenhagen and National Hospital, Denmark
Dr. Jagat R. Kanwar, Associate Professor, Laboratory of Immunology and Molecular Biomedical Research, Institute for Technology & Research Innovation, Deakin University, Australia
Dr. Jay Vadgama, Director, Molecular Oncology Program, Department of Medicine, Charles R. Drew University of Medicine and Science, USA
Dr. Jean-Louis Excler, Senior Director, Medical Affairs, International AIDS Vaccine Initiative (IAVI), Switzerland
Dr. Jerald C. Sadoff, President & CEO, Aeras Global TB Vaccine Foundation, The Netherlands
Dr. Jiaojiao lin, Professor & Deputy Director, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China
Dr. Jill Conley, Director, International and Precollege Science Education Programs, Howard Hughes Medical Institute, USA
Dr. Joanne Langley, Professor of Pediatrics, Departments of Pediatrics and Community Health and Epidemiology, Dalhousie University, Canada
Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA
Dr. Jonathan Liu, Director of R& D, Vaccine Development, MedImmune, USA
Dr. Jonathan P. Wong, Research Scientist, Molecular Biology Group, Chemical & Biologycal Defence Section, Defence R&D Canada, Canada
Dr. Jose Ignacio Santos, General Director, Hospital Infantil de Mexico Federico Gomez, National Institutes of Health, Mexico
Dr. Joseph Lustgarten, Associate Professor, Cancer Center Scottsdale, Mayo Clinic Arizona, USA
Dr. Juan J. Canales, Professor, University of Valencia-FGUV & Red de Trastornos Adictivos-RETICS, Spain
Dr. Julianna Lisziewicz, President, Genetic Immunity, LLC, USA
Dr. Kai Chen, Vice President, Business Development IOMAI Corporation, USA
Dr. Katherine Cohen, Vice President, Corporate & Business Development, Intercell AG, Austria
Dr. Kiyotaka Okuno, Principal Investigator, Department of Surgery, Kinki University School of Medicine, Japan
Dr. Klaus Hermansen, Senior Process Specialist, NNE Pharmaplan, Denmark
Dr. Kris Chadee, Professor, Department of Microbiology and Infectious Diseases, University of Calgary, Canada
Dr. Larry W. Kwak, Associate Director, Center for Cancer Immunology Research, USA
Dr. Lars T. Hellman, Professor, Uppsala University, Sweden
Dr. Lbachir BenMohamed, Director, University of California Irvine, USA
Dr. Linda K. Curtiss, Professor, The Scripps Research Institute; Chair of the Leadership Committee of the ATVB Council, USA
Dr. Lorne A. Babiuk, Director, Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada
Dr. Luc Aujame, Director, External R&D, Sanofi Pasteur, France
Dr. Larisa Rudenko, Head, Department of Virology, Director of BioDiem LTD, Institute of Experimental Medicine, Australia
Dr. Lutz Gissmann, Professor, German Cancer Research Centre, Germany
Dr. Lawrence D. Frenkel, Professor, University of Illinois College of Medicine, USA
Dr. Mady Hornig, Director of Translational Research Center for Infection and Immunity, Columbia University, USA
Dr. Magdalena Plebanski, Professor, Vaccine and Infectious Diseases Unit Monash University, Australia
Dr. Mansour Mohamadzadeh, Senior Investigator, United States Army Medical Research Institute for Infectious Diseases, USA
Dr. Marc Gurwith, Senior Vice President & CMO, Vaxgen Inc., USA
Dr. Marc S. Ernstoff, Professor of Medicine (Hematology-Oncology), Dartmouth Medical School, USA
Dr. Margaret Muganwa, Chairperson, Gender Davisory Committee, IAVI, Makerere University School of Public Health, Uganda
Dr. Martin Bachmann, CSO, Cytos Biotechnology, Switzerland
Dr. Martin Cranage, Hotung Chair of Molecular Vaccinology, St. George's University of London, UK
Dr. Mary Ng Mah Lee, Professor, Department of Microbiology, National University of Singapore, Singapore
Dr. Mary Slack, Head, Haemophilus Reference Unit (HRU), UK
Dr. Masato Tashiro, Director, National Institute of Infectious Diseases, Japan
Dr. Matthias von Herrath, Professor, La Jolla Institute for Allergy and Immunology, USA
Dr. Maurizio Memo, Professor of Pharmacology, University of Brescia, Italy
Dr. Menachem Rottem, Head, Division of Allergy, Asthma and Immunology, Ha’Emek Medical Center, Israel
Dr. Michael Favorov, Director General, International Vaccine Institute (IVI), Korea
Dr. Michael McHeyzer-Williams, Associate Professor, The Scripps Research Institute, USA
Dr. Mimi Tang, Director, Department of Allergy and Immunology Royal Children's Hospital, Australia
Dr. Mira Grdisa, Professor, Division of Molecular Medicine Rudjer Boskovic Institute, Croatia
Dr. Munir Alam, Associate Professor, Medicine and Pathology, Human Vaccine Institute, Duke University Medical Center, UK
Dr. Mohammad R. Pourmand, Assistant Proessor, Tehran University of Medical Sciences, Iran
Dr. Nathalie Garcon, Vice President; Head of Global Adjuvant Center for Vaccines, GlaxoSmithKline Biologicals, Belgium
Dr. Nathan Karin, Associate Professor, Technion- Israel Institute of Technology, Israel
Dr. Nigel J Temperton, Principal Investigator & Senior Research Fellow, University College London, UK
Dr. Nikolai Petrovsky, Secretary-General, International Immunomics Society, Australia
Dr. Ning-Sun Yang, Director, Institute of BioAgricultural Sciences, Academia Sinica, Taiwan
Dr. Opendra Narayan, Chairman, Molecular Genetics & Immunology, University of Kansas Medical Center, USA
Dr. Palok Aich, Senior Research Scientist, Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada
Dr. Patrick T. K. Woo, Professor, Department of Integrative Biology, University of Guelph, Canada
Dr. Patrick L. Leoni, Professor, Euromed Management, France
Dr. Paul-Pierre Pastoret, Head of Publications Department, World Organisation for Animal Health (OIE), Belgium
Dr. Pele Chong, Director & Distinguished Investigator, National Health Research Institute, Taiwan
Dr. Per Ljungman, Professor, Karolinska University Hospital, Karolinska Institute, Sweden
Dr. Peter Andersen, Vice Chairman, Department of Infectious Disease Immunology, Statens Serum Institute, Denmark
Dr. Peter G. Kremsner, Principal Investigator & Professor, Eberhard Karls University Tubingen, Germany
Dr. Peter Khoury, Vice President, Global Marketing Baxter Bioscience-Vaccines, USA
Dr. Peter Lachmann, President, Academy of Medical Sciences, UK
Dr. Peter Loudon, Research Director, PowderMed, USA
Dr. Pietro Mastroeni, Reader in Infection and Immunity, Centre for Veterinary Science, Department of Clinical Veterinary Medicine, University of Cambridge, UK
Dr. Pierre Tiollais,Director, Institut Pasteur, France
Dr. Ping Wang, Professor of Experimental Immunology Institute of Cell and Molecular Science, UK
Dr. Qiwei Zhang, Professor, Department of Mathematics The University of Hong Kong, China
Dr. Qing Yi, Associate Professor, Department of Lymphoma and Myeloma, Anderson Cancer Center, USA
Dr. R. Holland Cheng, Professor of Molecular and Cellular Biology, University California, USA
Dr. R. Madhubala, Professor, Life Sciences Jawahrlal Nehru University, India
Dr. Rachel Schneerson, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA
Dr. Rajiv Khanna, Director, Australian Centre for Vaccine Development, Australia
Dr. Ranjeny Thomas, Professor, Diamantina Institute for Cancer, Immunology, and Metabolic Medicine, University of Queensland, Australia
Dr. Ranjit R. Deshmukh, Senior Director & Process Owner, Technology Development and Transfer Process, Global Quality Operations, Wyeth Pharmaceuticals, USA
Dr. Ricardo Thompson, Scientific Director, National Institute of Health, Mozambique
Dr. Rino Rappuoli, Vice President & CSO, Biotech Company, Chiron, Italy
Dr. Robin Robinson, Senior Project Officer, Office of Research & Development Coordination, Office of Public Health Emergency Preparedness, US Department of Health & Human Services, USA
Dr. Roland Gohde, Director, Partec Essential Healthcare, Germany
Dr. Roger I. Glass, Director, Fogarty International Center at NIH, USA
Dr. Robert W. Gracy, Vice President for Research, University of North Texas Health Science Center, USA
Dr. Ruby Pawankar, President-Elect, World Allergy Organization, Japan
Dr. Robert Gracy, Vice President for research, University of North Texas Health Science Center, USA
Dr. Roland Gohde, Director, Partec Essential Healthcare, Germany
Dr. Ruiting Lan, Associate Professor, University of New South Wales Sydney, Australia
Dr. Salah Al-Awaidy, Director, Department of Communicable Disease Surveillance & Control, Oman
Dr. Sarah Sheridan, Director, BioReliance Ltd, UK
Dr. Steven Jerome McCadney, Professor, Yeshiva University, USA
Dr. Sean Li, Professor, Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada
Dr. Shahid Abbas, Head, Allergy Vaccine Production, NIH, Pakistan
Dr. Shaun Heaphy, Professor, Infection Immunity and Inflammation, University of Leicester, UK
Dr. Stefano Buttò, Director, Division of Retrovirus Infections in Developing Countries of National AIDS Center, Italy
Dr. Stephen Albert Johnston, Director, Center for Innovations in Medicine Biodesign Institute, Arizona State University, USA
Dr. Surasak Phuphanich, Director, Cedars-Sinai Medical Center, USA
Dr. Sunyoung Kim, Professor, Institute of Molecular Biology and Genetics Seoul National University, Korea
Dr. Supachai Recks Ngram, Senior Expert in Preventive Medicine Ministry of Public Health, Thailand
Dr. Suresh Jadhav, Executive Director, Serum Institute of India Ltd, India
Dr. Thomas Muster, CEO, AVIR Green Hills Biotechnology, Austria
Dr. Tikki Pang, Director, Research Policy & Cooperation (RPC/IER), World Health Organization, Switzerland
Dr. Tohru Hasegawa, Professor, University of North Dakota, USA
Dr. Tomas Jelinek, Medical Director, the Berlin Centre for Travel & Tropical Medicine, Germany
Dr. Tom Ottenhoff, Professor, Department Immunohematology and Blood Transfusion, Leiden University Medical Center, Netherlands
Dr. V. A. Srinivasan, Research Director, Indian Immunology Ltd, India
Dr. Victor Bronshtein, President & CSO, Universal Stabilization Technologies, Inc., USA
Dr. Vadim Tsvetnitsky, Technical Officer, Vaccine Development Global Program, PATH, USA
Dr. Vadim Tsvetnitsky, Technical Officer, Vaccine Development Global Program, PATH, USA
Dr. Vasso Apostolopoulos, Professor, Burnet Institute, Australia
Dr. Vernon Stevens, Professor, College of Medicine, Department of Obstetrics and Gynecology, Ohio State University, USA
Dr. Victor Carey, Medical Director Asia-Pacific, Sanofi pasteur, France
Dr. Vidadi Yusibov, Executive Director, Fraunhofer Center for Molecular Biotechnology, USA
Dr. Vijaya Lakshmi Valluri, Group Leader for the Immunology & Molecular Biology Division, India
Dr. Viroj Wiwanitkit, Professor, Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Thailand
Dr. Wiebren A. A. Tjalma, Professor, Department of Gynaecology, University Hospital Antwerpen, Belgium
Dr. William Soo Hoo, Vice President, Adjumatrix Technologies, Inc., USA
Dr. Xiang-Yang (Shawn) Wang, Associate Professor, Virginia Commonwealth University School of Medicine, USA
Dr. Xuelian Zhang, Associate Professor, School of Life Sciences, Fudan University, China
Dr. Yasmin Thanavala, Search Committee Chair, Department of Immunology, Roswell Park Cancer Institute, USA
Dr. Zhenhua Yang, Associate Professor, Department of Epidemiology, School of Public Health, University of Michigan, USA
Dr. Zhiping Ye, Deputy Director, Laboratory of Pediatric and Respiratory Virus Diseases, Division of Viral Products, Office of Vaccines Research and Review, USA
Dr. Zhi Q. Yao, Director, James H. Quillen VA Medical Center, USA
|
